Literature DB >> 33222393

Maximizing the potential of the Salt Substitute in India Study.

Aayush Visaria1, Jai Shahani1, Megh Shah1, Anurag Modak1,2, Rachana Chilakapati1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33222393      PMCID: PMC8029723          DOI: 10.1111/jch.14109

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
To the Editor: We read with pleasure the article by Thout et al, titled “Rationale, design, and baseline characteristics of the Salt Substitute in India Study (SSiIS): The protocol for a double‐blinded, randomized‐controlled trial” that described a trial assessing the impact of substituting usual salt (100% sodium chloride) with salt substitute (70% sodium chloride and 30% potassium chloride) on blood pressure (BP). Upon comparison with related trials and in context of recent research on BP variability, we propose the following modifications to maximize the potential of the trial: A limitation of prior studies , , , has been the lack of measurement of covariates at multiple visits. While most baseline characteristics and laboratory values do not change significantly from initial to final visit, it would be presumptive to conclude that change in blood pressure was due to the intervention without measuring change in covariates like lipid levels, fasting glucose, and smoking and alcohol consumption, among others. By measuring time‐varying covariates at least at the initial and final visits, it would allow the authors to not only determine any emerging biases between intervention and control groups, but also potentially elucidate indirect mechanisms for trial findings. One such indirect mechanism is the Hawthorne Effect, the idea that if participants know their diet is being observed as part of a study, they may be more conscious of what they are eating. A prior salt substitute trial in rural China followed participants for three years and found that, while three‐month changes in BP were high, changes dropped significantly at six months in both control and intervention groups and modestly increased thereafter. This begs the question of whether six months is an appropriate, evidence‐based follow‐up time to determine the effectiveness of the salt substitute. Ultimately, this is a decision we are sure the authors have determined as per logistical constraints and research evidence, but we propose that a one‐year study may better assess the long‐term sustainability of the intervention. Subjects with higher baseline BPs may be more likely to observe a greater decrease in BP, biasing results toward such participants’ outcomes. , A participant with a systolic BP of 160 may find it easier to reduce from 160 to 140, as opposed to a participant with a systolic BP of 130 trying to reduce to 110, despite both being a 20‐mmHg decrease. Rather than looking at only absolute measures, we propose the authors should additionally consider relative measures such as percent decrease. BP fluctuates throughout the day, so a single average reading may not be an accurate representation of one's BP. Furthermore, BP variability is increasingly being recognized as an independent predictor of cardiovascular disease. , , , , While it may be difficult to invest in and enforce 24‐hour ambulatory BP monitoring, which is the gold standard for BP monitoring, authors may use this trial as an opportunity to collect BP data more rigorously through home‐based BP monitoring. Additionally, measurement of BP at the first, third, and fifth visits allows for calculation of visit‐to‐visit BP variability. Visit‐to‐visit BP variability is the most studied form of BP variability , but has not been studied adequately in the Indian population, and thus, this serves as an interesting corollary, secondary analysis of trial data. Because this study is conducted among rural Indians with strict inclusion criteria and fairly well‐controlled hypertension (as per baseline mean BPs), it may not be generalizable to the urban Indian and foreign population whose diet and lifestyles are likely different. It would be interesting to compare the intervention's effectiveness across those with uncontrolled vs. controlled hypertension.

CONFLICT OF INTEREST

The authors declare that they have no competing interests.

ETHICS APPROVAL

This study was exempt from Rutgers's Institutional Review Board approval.

Funding Information

No funding provided for this study.
  11 in total

1.  Interim effects of salt substitution on urinary electrolytes and blood pressure in the China Salt Substitute and Stroke Study (SSaSS).

Authors:  Liping Huang; Maoyi Tian; Jie Yu; Qiang Li; Yishu Liu; Xuejun Yin; Jason Hy Wu; Matti Marklund; Yangfeng Wu; Nicole Li; Paul Elliott; Lijing L Yan; Darwin R Labarthe; Zhixin Hao; Jingpu Shi; Xiangxian Feng; Jianxin Zhang; Yuhong Zhang; Ruijuan Zhang; Bo Zhou; Zhifang Li; Jixin Sun; Yi Zhao; Yan Yu; Bruce Neal
Journal:  Am Heart J       Date:  2020-01-07       Impact factor: 4.749

2.  Visit-to-visit and ambulatory blood pressure variability as predictors of incident cardiovascular events in patients with hypertension.

Authors:  Kazuo Eguchi; Satoshi Hoshide; Joseph E Schwartz; Kazuyuki Shimada; Kazuomi Kario
Journal:  Am J Hypertens       Date:  2012-06-28       Impact factor: 2.689

3.  Considerations in study design and interpretation when assessing visit-to-visit blood pressure variability.

Authors:  Aayush Visaria
Journal:  J Hypertens       Date:  2020-08       Impact factor: 4.844

4.  Prognostic value of 24-hour blood pressure variability.

Authors:  A Frattola; G Parati; C Cuspidi; F Albini; G Mancia
Journal:  J Hypertens       Date:  1993-10       Impact factor: 4.844

5.  Salt substitution: a low-cost strategy for blood pressure control among rural Chinese. A randomized, controlled trial.

Authors: 
Journal:  J Hypertens       Date:  2007-10       Impact factor: 4.844

6.  Using a low-sodium, high-potassium salt substitute to reduce blood pressure among Tibetans with high blood pressure: a patient-blinded randomized controlled trial.

Authors:  Xingshan Zhao; Xuejun Yin; Xian Li; Lijing L Yan; Christopher T Lam; Shenshen Li; Feng He; Wuxiang Xie; Ba Sang; Gesang Luobu; Liang Ke; Yangfeng Wu
Journal:  PLoS One       Date:  2014-10-22       Impact factor: 3.240

7.  Rationale, design, and baseline characteristics of the Salt Substitute in India Study (SSiIS): The protocol for a double-blinded, randomized-controlled trial.

Authors:  Sudhir Raj Thout; Jie Yu; Maoyi Tian; Mark D Huffman; Clare Arnott; Qiang Li; Praveen Devarsetty; Claire Johnson; Simone Pettigrew; Bruce Neal; Jason H Y Wu
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-07-25       Impact factor: 3.738

8.  The Hawthorne Effect: a randomised, controlled trial.

Authors:  Rob McCarney; James Warner; Steve Iliffe; Robbert van Haselen; Mark Griffin; Peter Fisher
Journal:  BMC Med Res Methodol       Date:  2007-07-03       Impact factor: 4.615

Review 9.  Blood pressure variability and cardiovascular disease: systematic review and meta-analysis.

Authors:  Sarah L Stevens; Sally Wood; Constantinos Koshiaris; Kathryn Law; Paul Glasziou; Richard J Stevens; Richard J McManus
Journal:  BMJ       Date:  2016-08-09

10.  Maximizing the potential of the Salt Substitute in India Study.

Authors:  Aayush Visaria; Jai Shahani; Megh Shah; Anurag Modak; Rachana Chilakapati
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-11-21       Impact factor: 3.738

View more
  2 in total

Review 1.  Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women.

Authors:  Amanda Brand; Marianne E Visser; Anel Schoonees; Celeste E Naude
Journal:  Cochrane Database Syst Rev       Date:  2022-08-10

2.  Maximizing the potential of the Salt Substitute in India Study.

Authors:  Aayush Visaria; Jai Shahani; Megh Shah; Anurag Modak; Rachana Chilakapati
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-11-21       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.